Evidence map›Paper›PMID 34737870›Full record

ArticleJournal of global health2021

Research priorities to address the global burden of chronic obstructive pulmonary disease (COPD) in the next decade.

Davies Adeloye, Dhiraj Agarwal, Peter J Barnes, Marcel Bonay, Job F van Boven, Jamie Bryant, Gaetano Caramori, David Dockrell, Anthony D'Urzo, Magnus Ekström and 28 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Journal of global health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06862713 (Determination of the Effects of Walking and Home-Based Pulmonary Rehabilitation on Anxiety and Sleep Quality in Patients With Chronic Obstructive Pulmonary Disease), which is not on this map. Cited by 21 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 2 pooled it
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06862713 nacompletednot on this mapstarted 2024, after this paper: background citation

Determination of the Effects of Walking and Home-Based Pulmonary Rehabilitation on Anxiety and Sleep Quality in Patients With Chronic Obstructive Pulmonary Disease: A Randomized Controlled Trial

TypeinterventionalSponsorBilecik Seyh Edebali UniversitesiRan2024 to 2025Enrolled90ConditionsChronic Obstructive Pulmonary Disease (COPD)Armspulmonary rehabilitation exercise
3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 2 syntheses or guidelines pooled it, 41 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Global respiratory health priorities at the beginning of the 21st century.European respiratory review : an official journal of the European Respiratory Society · 2024
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Observational
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

38 authors at 20 institutions in 17 countries.

Davies AdeloyeUsher Institute, University of Edinburgh, Edinburgh, UK.
Dhiraj AgarwalVadu Rural Health Program, KEM Hospital Research Centre, Pune, India.
Peter J BarnesImperial College London, UK.
Marcel BonayUniversity of Versailles, Versailles, France.
Job F van BovenUniversity of Groningen, University Medical Center Groningen, Groningen Research Institute for Asthma and COPD (GRIAC), Department of Clinical Pharmacy & Pharmacology, Groningen, the Netherlands.
Jamie BryantUniversity of Newcastle, Newcastle, New South Wales, Australia.
Gaetano CaramoriUniversity of Messina, Messina, Italy.
David DockrellCentre for Inflammation Research, University of Edinburgh, Edinburgh, UK.
Anthony D'UrzoUniversity of Toronto, Toronto, Ontario, Canada.
Magnus EkströmLund University, Lund, Sweden.
Gregory ErhaborObafemi Awolowo University, Ile-Ife, Nigeria.
Cristóbal EstebanGaldakao-Usansolo Hospital, Galdakao, Bizkaia, Spain.
Catherine M GreeneRoyal College of Surgeons in Ireland, Dublin, Ireland.
John HurstUCL Respiratory, University College London, UK.
Sanjay JuvekarVadu Rural Health Program, KEM Hospital Research Centre, Pune, India.
Ee Ming KhooFaculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
Fanny W KoThe Chinese University of Hong Kong, Hong Kong.
Brian LipworthScottish Centre for Respiratory Research, University of Dundee, Dundee, UK.
Jose L López-CamposUnidad Médico-Quirúrgica de Enfermedades Respiratorias, Instituto de Biomedicina de Sevilla (IBiS); Hospital Universitario Virgen del Rocio - Universidad de Sevilla - CIBERES, Spain.
Matthew MaddocksKings College London, UK.
David M ManninoUniversity of Kentucky, Lexington, Kentucky, USA.
Fernando J MartinezWeill Cornell Medicine, New York City, New York, USA.
Miguel A Martinez-GarciaHospital Universitario y Politécnico de La Fe, Valencia, Spain.
Renae J McNamaraThe University of Sydney, New South Wales, Australia.
Marc MiravitllesPneumology Department, University Hospital Vall d'Hebron and Vall d'Hebron Institut de Recerca (VHIR), Barcelona, Spain.
Hilary PinnockUsher Institute, University of Edinburgh, Edinburgh, UK.
Alison PoolerKeele University, Keele, UK.
Jennifer K QuintImperial College London, UK.
Peter SchwarzBone-metabolic Research Unit, Copenhagen University Hospital Rigshospitalet, Denmark.
George M SlavichCousins Center for Psychoneuroimmunology and Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, California, USA.
Peige SongSchool of Public Health, Zhejiang University School of Medicine, Hangzhou, China.
Andrew TaiWomen's and Children's Hospital, Adelaide, South Australia, Australia.
Henrik WatzPulmonary Research Institute at Lungen Clinic Grosshansdorf, Airway Research Center North (ARCN), German Centre for Lung Research (DZL), Germany.
Jadwiga A WedzichaImperial College London, UK.
Michelle C WilliamsCentre for Cardiovascular Science, The Queen's Medical Research Institute, University of Edinburgh, Edinburgh, UK.
Harry CampbellUsher Institute, University of Edinburgh, Edinburgh, UK.
Aziz SheikhUsher Institute, University of Edinburgh, Edinburgh, UK.
Igor RudanUsher Institute, University of Edinburgh, Edinburgh, UK.
University of Edinburgh · GBImperial College London · GBCopenhagen University Hospital · DKDr. D. Y. Patil Medical College, Hospital and Research Centre · INCentre for Inflammation Research · GBCentro de Investigación Biomédica en Red de Enfermedades Respiratorias · ESChinese University of Hong Kong · HKCornell University · USGerman Center for Lung Research · DEHospital de Galdakao · ESHospital Universitari i Politècnic La Fe · ESInstitut Lavoisier de Versailles · FRKing's College London · GBLund University · SEObafemi Awolowo University · NGRoyal College of Surgeons in Ireland · IEThe Queen's Medical Research Institute · GBThe University of Sydney · AUUniversity College London · GBUniversity Medical Center Groningen · NL

Funding

Medical Research Council G1001372Medical Research Council MC_PC_19004Medical Research Council MR/N02995X/1Medical Research Council MR/S019669/1
6 · The paper itself

Abstract

backgroundThe global prevalence of chronic obstructive pulmonary disease (COPD) has increased markedly in recent decades. Given the scarcity of resources available to address global health challenges and respiratory medicine being relatively under-invested in, it is important to define research priorities for COPD globally. In this paper, we aim to identify a ranked set of COPD research priorities that need to be addressed in the next 10 years to substantially reduce the global impact of COPD.

methodsWe adapted the Child Health and Nutrition Research Initiative (CHNRI) methodology to identify global COPD research priorities.

results62 experts contributed 230 research ideas, which were scored by 34 researchers according to six pre-defined criteria: answerability, effectiveness, feasibility, deliverability, burden reduction, and equity. The top-ranked research priority was the need for new effective strategies to support smoking cessation. Of the top 20 overall research priorities, six were focused on feasible and cost-effective pulmonary rehabilitation delivery and access, particularly in primary/community care and low-resource settings. Three of the top 10 overall priorities called for research on improved screening and accurate diagnostic methods for COPD in low-resource primary care settings. Further ideas that drew support involved a better understanding of risk factors for COPD, development of effective training programmes for health workers and physicians in low resource settings, and evaluation of novel interventions to encourage physical activity.

conclusionsThe experts agreed that the most pressing feasible research questions to address in the next decade for COPD reduction were on prevention, diagnosis and rehabilitation of COPD, especially in low resource settings. The largest gains should be expected in low- and middle-income countries (LMIC) settings, as the large majority of COPD deaths occur in those settings. Research priorities identified by this systematic international process should inform and motivate policymakers, funders, and researchers to support and conduct research to reduce the global burden of COPD.

Indexed as

Child HealthPulmonary Disease, Chronic ObstructiveChildGlobal HealthHumansPovertyResearch Design

Identifiers

PMID34737870
PMCPMC8542376
OpenAlexW3208146640

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.